These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17918102)

  • 21. [The effectiveness and safety of botulinum toxin in the treatment of chronic primary headaches].
    Volcy-Gómez M
    Rev Neurol; 2004 Aug 16-31; 39(4):388-93. PubMed ID: 15340901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Botulinum toxin type A as an effective prophylactic treatment in primary headache disorders.
    Blumenfeld A
    Headache; 2003 Sep; 43(8):853-60. PubMed ID: 12940806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Botulinum toxin type A (Botox) in the treatment of migraine and other headaches.
    Troost BT
    Expert Rev Neurother; 2004 Jan; 4(1):27-31. PubMed ID: 15853612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Influence of botulinum toxin treatment on previous primary headaches in patients with cranio-cervical dystonia].
    Pascual J
    Neurologia; 2004 Jun; 19(5):260-3. PubMed ID: 15150709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum toxin type A for the treatment of headache: why we say yes.
    Ashkenazi A; Silberstein S
    Arch Neurol; 2008 Jan; 65(1):146-9. PubMed ID: 18195155
    [No Abstract]   [Full Text] [Related]  

  • 26. Long-term clinical outcome after botulinum toxin injection in children with nonrelaxing internal anal sphincter.
    Chumpitazi BP; Fishman SJ; Nurko S
    Am J Gastroenterol; 2009 Apr; 104(4):976-83. PubMed ID: 19259081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botulinum A toxin intravesical injection in patients with painful bladder syndrome: 1-year followup.
    Giannantoni A; Porena M; Costantini E; Zucchi A; Mearini L; Mearini E
    J Urol; 2008 Mar; 179(3):1031-4. PubMed ID: 18206941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The long-term efficacy of fissurectomy and botulinum toxin injection for chronic anal fissure in females.
    Baraza W; Boereboom C; Shorthouse A; Brown S
    Dis Colon Rectum; 2008 Feb; 51(2):239-43. PubMed ID: 18175186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Long-term prognosis of analgesics abuse headache].
    Takase Y; Kishigami H; Nakano M; Tatsumi C
    Rinsho Shinkeigaku; 2005 Sep; 45(9):629-33. PubMed ID: 16248393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparing two types of botulinum-A toxin detrusor injections in patients with severe neurogenic detrusor overactivity: a case-control study.
    Grosse J; Kramer G; Jakse G
    BJU Int; 2009 Sep; 104(5):651-6. PubMed ID: 19281462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum toxin for recurrent anal fissure following lateral internal sphincterotomy.
    Brisinda G; Cadeddu F; Brandara F; Marniga G; Vanella S; Nigro C; Maria G
    Br J Surg; 2008 Jun; 95(6):774-8. PubMed ID: 18425796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short-term efficacy of botulinum toxin a for refractory overactive bladder in the elderly population.
    White WM; Pickens RB; Doggweiler R; Klein FA
    J Urol; 2008 Dec; 180(6):2522-6. PubMed ID: 18930481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of headaches with botulinum toxin.
    Samton J; Mauskop A
    Expert Rev Neurother; 2006 Mar; 6(3):313-22. PubMed ID: 16533136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Botulinum toxin injections for chronic migraine in adolescents - an early therapeutic option in the transition from neuropaediatrics to neurology].
    Bernhard MK; Bertsche A; Syrbe S; Weise S; Merkenschlager A
    Fortschr Neurol Psychiatr; 2014 Jan; 82(1):39-42. PubMed ID: 24446117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prospective study of the clinical and urodynamic results of intradetrusor botulinum toxin injections for the treatment of neurogenic overactive bladder].
    Bentaleb Y; Castel-Lacanal E; Sallusto F; De Boissezon X; Malavaud B; Marque P; Rischmann P; Gamé X
    Prog Urol; 2008 Jul; 18(7):449-55. PubMed ID: 18602606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Botulinum toxin type-A (BOTOX) in the treatment of occipital neuralgia: a pilot study.
    Taylor M; Silva S; Cottrell C
    Headache; 2008; 48(10):1476-81. PubMed ID: 19076646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurogenic detrusor overactivity treated with english botulinum toxin a: 8-year experience of one single centre.
    Del Popolo G; Filocamo MT; Li Marzi V; Macchiarella A; Cecconi F; Lombardi G; Nicita G
    Eur Urol; 2008 May; 53(5):1013-19. PubMed ID: 17950989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Botox therapy for refractory chronic migraine.
    Conway S; Delplanche C; Crowder J; Rothrock J
    Headache; 2005 Apr; 45(4):355-7. PubMed ID: 15836573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of botulinum toxin type A in the treatment of lateral crow's feet: double-blind, placebo-controlled, dose-ranging study.
    Ascher B; Rzany BJ; Grover R
    Dermatol Surg; 2009 Oct; 35(10):1478-86. PubMed ID: 19686365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of Frey's syndrome with botulinum toxin.
    Pomprasit M; Chintrakarn C
    J Med Assoc Thai; 2007 Nov; 90(11):2397-402. PubMed ID: 18181326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.